&nbsp;

Dec 1969

Drug

nelarabine

Other Name(s): Atriance®

Quick Link(s):

Dec 1969

Drug

oBINutuzumab

Other Name(s): Gazyva®

Quick Link(s):

Dec 1969

Drug

nivolumab

Other Name(s): Opdivo®

Quick Link(s):

Oct 2024

Regimen

NPAC

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Metastatic Breast Cancer

Drugs Used:

nab-PACLitaxel

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

OXALRALT

Cancer Type:

Gastrointestinal,

Colorectal,

Esophagus,

Gastric / Stomach,

Small bowel and appendix

Intent: Adjuvant, Palliative

Funding:

New Drug Funding Program

Raltitrexed - Metastatic Colorectal Small Bowel or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Metastatic Esophageal, Gastroesophageal Junction, or Gastric Cancer

New Drug Funding Program

Raltitrexed - Adjuvant Colorectal, Small Bowel, or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Adjuvant Esophageal, Gastroesophageal Junction, or Gastric Cancer

Drugs Used:

raltitrexed,

oxaliplatin

Quick Link(s):

Regimen Monograph

Regimen

NPAC(W)

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Metastatic Breast Cancer

Drugs Used:

nab-PACLitaxel

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

NPAC(W)

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Hypersensitivity Reactions to Taxanes

Drugs Used:

nab-PACLitaxel

Quick Link(s):

Regimen Monograph

Regimen

NPAC+PERT+TRAS

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer

New Drug Funding Program

Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer

New Drug Funding Program

Nab-Paclitaxel - Metastatic Breast Cancer

Drugs Used:

PERTuzumab,

trastuzumab,

nab-PACLitaxel (Unfunded with exceptions)

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

NPAC(W)+PERT+TRAS

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer

New Drug Funding Program

Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer

New Drug Funding Program

Nab-Paclitaxel - Metastatic Breast Cancer

Drugs Used:

PERTuzumab,

trastuzumab,

nab-PACLitaxel (Unfunded with exceptions)

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

NIVL

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab - Advanced Melanoma (Unresectable or Metastatic Melanoma)

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Regimen

NIVL+IPIL

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - Advanced Melanoma (Unresectable or Metastatic Melanoma)

New Drug Funding Program

Nivolumab plus Ipilimumab - Advanced Melanoma (Unresectable or Metastatic Melanoma)

Drugs Used:

nivolumab,

ipilimumab